NO20010860L - Nye forbindelser - Google Patents
Nye forbindelserInfo
- Publication number
- NO20010860L NO20010860L NO20010860A NO20010860A NO20010860L NO 20010860 L NO20010860 L NO 20010860L NO 20010860 A NO20010860 A NO 20010860A NO 20010860 A NO20010860 A NO 20010860A NO 20010860 L NO20010860 L NO 20010860L
- Authority
- NO
- Norway
- Prior art keywords
- new connections
- prevention
- formula
- treatment
- acceptable salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Nye forbindelser, og terapeutisk akseptable salter derav av formel (I) I som inhiberer eksogent eller endogent stimulert mavesyresekresjon og således kan anvendes i forebyggelse og behandling av gastrointestinale inflammatoriske sykdommer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802794A SE9802794D0 (sv) | 1998-08-21 | 1998-08-21 | New compounds |
PCT/SE1999/001402 WO2000011000A2 (en) | 1998-08-21 | 1999-08-18 | New compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010860D0 NO20010860D0 (no) | 2001-02-20 |
NO20010860L true NO20010860L (no) | 2001-04-23 |
Family
ID=20412307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010860A NO20010860L (no) | 1998-08-21 | 2001-02-20 | Nye forbindelser |
Country Status (20)
Country | Link |
---|---|
US (3) | US6579884B1 (no) |
EP (2) | EP1411056A3 (no) |
JP (1) | JP2002523415A (no) |
KR (1) | KR20010072798A (no) |
CN (1) | CN1329613A (no) |
AR (1) | AR020226A1 (no) |
AT (1) | ATE280768T1 (no) |
AU (1) | AU5767999A (no) |
BR (1) | BR9913103A (no) |
CA (1) | CA2339286A1 (no) |
DE (1) | DE69921483T2 (no) |
DK (1) | DK1105391T3 (no) |
ES (1) | ES2229763T3 (no) |
IL (1) | IL141166A0 (no) |
NO (1) | NO20010860L (no) |
PT (1) | PT1105391E (no) |
SE (1) | SE9802794D0 (no) |
SI (1) | SI1105391T1 (no) |
WO (1) | WO2000011000A2 (no) |
ZA (1) | ZA200100913B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
SE0003186D0 (sv) * | 2000-09-07 | 2000-09-07 | Astrazeneca Ab | New process |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
SE0102808D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | New compounds |
MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
DE60318321T2 (de) * | 2002-09-19 | 2008-12-11 | Schering Corp. | Pyrazolopyridine als hemmstoffe cyclin abhängiger kinasen |
EP1539756B1 (en) * | 2002-09-19 | 2007-11-14 | Schering Corporation | Imidazopyridines as cyclin dependent kinase inhibitors |
ATE447555T1 (de) | 2003-03-10 | 2009-11-15 | Nycomed Gmbh | Neues verfahren zur herstellung vonroflumilast |
SE0301904D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound II with therapeutic effect |
US8536492B2 (en) * | 2003-10-27 | 2013-09-17 | Applied Materials, Inc. | Processing multilayer semiconductors with multiple heat sources |
KR20060099524A (ko) | 2003-11-03 | 2006-09-19 | 아스트라제네카 아베 | 무증상 위식도 역류의 치료를 위한 이미다조[1,2-a]피리딘유도체 |
US20080033006A1 (en) * | 2004-01-26 | 2008-02-07 | Altana Pharma Ag | 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors |
KR102152809B1 (ko) * | 2004-07-28 | 2020-09-07 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도 |
EP2258350B1 (en) * | 2005-03-16 | 2014-12-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
JP2010511019A (ja) * | 2006-12-01 | 2010-04-08 | ガラパゴス・ナムローゼ・フェンノートシャップ | 変性疾患及び炎症性疾患の治療に有用なイミダゾロピリジン化合物 |
WO2009042907A1 (en) * | 2007-09-27 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
BRPI1013288A2 (pt) | 2009-07-09 | 2016-03-29 | Raqualia Pharma Inc | uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto |
CN111606846A (zh) * | 2020-05-12 | 2020-09-01 | 广州理文科技有限公司 | 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA81219B (en) * | 1980-01-23 | 1982-01-27 | Schering Corp | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them |
EP0068378B1 (en) * | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
US4725601A (en) | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
US5574042A (en) * | 1992-11-02 | 1996-11-12 | Fujisawa Pharmaceutical Co., Ltd | Imidazo [1,2-a] pyridines and their pharmaceutical use |
IL108520A (en) * | 1993-02-15 | 1997-09-30 | Byk Gulden Lomberg Chem Fab | 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
AU6646094A (en) | 1993-04-22 | 1994-11-08 | Byk Gulden | New pyridinium salts and their use for controlling helicobacter bacteria |
UA48122C2 (uk) | 1993-10-11 | 2002-08-15 | Бік Гульден Ломберг Хеміше Фабрік Гмбх | АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ |
AU700737B2 (en) | 1994-07-28 | 1999-01-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzylimidazopyridines |
EP0772614A1 (de) | 1994-07-28 | 1997-05-14 | Byk Gulden Lomberg Chemische Fabrik GmbH | Halogenimidazopyridine |
SK197A3 (en) | 1994-07-28 | 1997-06-04 | Byk Gulden Lomberg Chem Fab | Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use |
CA2196076A1 (en) | 1994-07-28 | 1996-02-08 | Gerhard Grundler | Acyl imidazopyridines |
DE19602853A1 (de) | 1996-01-26 | 1997-07-31 | Byk Gulden Lomberg Chem Fab | Neue Halogenimidazopyridine |
ATE294802T1 (de) | 1996-01-26 | 2005-05-15 | Altana Pharma Ag | 3-alkylimidazopyridine |
SE9700661D0 (sv) * | 1997-02-25 | 1997-02-25 | Astra Ab | New compounds |
SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
SE9802793D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
-
1998
- 1998-08-21 SE SE9802794A patent/SE9802794D0/xx unknown
-
1999
- 1999-08-18 BR BR9913103-0A patent/BR9913103A/pt not_active Application Discontinuation
- 1999-08-18 WO PCT/SE1999/001402 patent/WO2000011000A2/en active IP Right Grant
- 1999-08-18 EP EP03028150A patent/EP1411056A3/en not_active Withdrawn
- 1999-08-18 CA CA002339286A patent/CA2339286A1/en not_active Abandoned
- 1999-08-18 PT PT99944966T patent/PT1105391E/pt unknown
- 1999-08-18 EP EP99944966A patent/EP1105391B1/en not_active Expired - Lifetime
- 1999-08-18 CN CN99812176A patent/CN1329613A/zh active Pending
- 1999-08-18 ES ES99944966T patent/ES2229763T3/es not_active Expired - Lifetime
- 1999-08-18 AT AT99944966T patent/ATE280768T1/de not_active IP Right Cessation
- 1999-08-18 IL IL14116699A patent/IL141166A0/xx unknown
- 1999-08-18 KR KR1020017002152A patent/KR20010072798A/ko not_active Application Discontinuation
- 1999-08-18 AU AU57679/99A patent/AU5767999A/en not_active Abandoned
- 1999-08-18 US US09/402,919 patent/US6579884B1/en not_active Expired - Lifetime
- 1999-08-18 DK DK99944966T patent/DK1105391T3/da active
- 1999-08-18 SI SI9930698T patent/SI1105391T1/xx unknown
- 1999-08-18 DE DE69921483T patent/DE69921483T2/de not_active Expired - Fee Related
- 1999-08-18 JP JP2000566273A patent/JP2002523415A/ja active Pending
- 1999-08-19 AR ARP990104163A patent/AR020226A1/es unknown
-
2001
- 2001-02-01 ZA ZA200100913A patent/ZA200100913B/en unknown
- 2001-02-20 NO NO20010860A patent/NO20010860L/no not_active Application Discontinuation
-
2003
- 2003-05-05 US US10/429,639 patent/US6790960B2/en not_active Expired - Lifetime
-
2004
- 2004-06-30 US US10/882,097 patent/US20050154007A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000011000A2 (en) | 2000-03-02 |
DK1105391T3 (da) | 2005-01-24 |
KR20010072798A (ko) | 2001-07-31 |
AR020226A1 (es) | 2002-05-02 |
EP1105391A2 (en) | 2001-06-13 |
EP1105391B1 (en) | 2004-10-27 |
AU5767999A (en) | 2000-03-14 |
NO20010860D0 (no) | 2001-02-20 |
JP2002523415A (ja) | 2002-07-30 |
PT1105391E (pt) | 2005-01-31 |
US6790960B2 (en) | 2004-09-14 |
DE69921483T2 (de) | 2006-02-02 |
US20030220364A1 (en) | 2003-11-27 |
US20050154007A1 (en) | 2005-07-14 |
DE69921483D1 (de) | 2004-12-02 |
ZA200100913B (en) | 2002-05-02 |
BR9913103A (pt) | 2001-05-08 |
ES2229763T3 (es) | 2005-04-16 |
IL141166A0 (en) | 2002-02-10 |
CN1329613A (zh) | 2002-01-02 |
SI1105391T1 (en) | 2005-02-28 |
EP1411056A3 (en) | 2004-04-28 |
EP1411056A2 (en) | 2004-04-21 |
WO2000011000A3 (en) | 2000-06-15 |
ATE280768T1 (de) | 2004-11-15 |
US6579884B1 (en) | 2003-06-17 |
SE9802794D0 (sv) | 1998-08-21 |
CA2339286A1 (en) | 2000-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010860L (no) | Nye forbindelser | |
NO20010861L (no) | Nye forbindelser | |
SE9801526D0 (sv) | New compounds | |
SE9704404D0 (sv) | New compounds | |
TR200100805T2 (tr) | Tetrahidropiridoeterler | |
SE9700661D0 (sv) | New compounds | |
SE9401197D0 (sv) | Active compounds | |
CA2256687A1 (en) | Benzimidazole derivatives for treating gastrointestinal inflammatory diseases | |
SE0102808D0 (sv) | New compounds | |
ATE311389T1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
NO954928L (no) | Nye aktive forbindelser | |
SE0301905D0 (sv) | Novel imidazopyridine compound I with therapeutic effect | |
NZ329716A (en) | Sulfonamide substituted derivatives and medicaments thereof | |
MY140718A (en) | Novel imidazopyridine compound ii with therapeutic effect | |
SE0301903D0 (sv) | Novel imidazopyridine compound III with therapeutic effect | |
ATE382616T1 (de) | Neue verbindungen | |
AR044854A1 (es) | Compuesto de imidazopiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |